Colonisation of the airways with Ureaplasma urealyticum as a risk factor for bronchopulmonary dysplasia in VLBW infants?;Chronische atemstörung sehr kleiner frühgeborener: Besiedlung mit Ureaplasma urealyticum als ätiologischer faktor?

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 206, Issue 5, 2002, Pages 187-192

  Ruf, Bettina ^a   Klauwer, D ^a   Reiss, I ^a   Schiefer, H G ^a   Gortner, L ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Bronchopulmonary dysplasia; Ureaplasma urealyticum; VLBW

Indexed keywords

BETAMETHASONE; ERYTHROMYCIN; LUNG SURFACTANT EXTRACT;

ARTICLE; BACTERIAL COLONIZATION; BIRTH WEIGHT; DELIVERY; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; LUNG INFECTION; MATERNAL DISEASE; MULTIVARIATE ANALYSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXYGEN SATURATION; OXYGEN SUPPLY; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; UREAPLASMA UREALYTICUM; VERY LOW BIRTH WEIGHT;

BACTERIOLOGICAL TECHNIQUES; BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; MALE; OXYGEN INHALATION THERAPY; PHARYNX; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM; VIRULENCE;

EID: 18744366038     PISSN: 09482393     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34964     Document Type: Article

References (29)

1. Groneck P, Schmale J, Soditt V, Stutzer H, Gotze-Speer B, Speer CP. Bronchoalveolar inflammation following airway infection in infants with chronic lung disease. Pediatr Pulmonol 2001; 31: 331-338
2. Egreteau L, Pauchard JY, Semama DS, Matis J, Liska A, Romeo B, Cneude F, Hamon I, Truffert P. Chronic oxygen dependency in infants born at less than 32 weeks' gestation: Incidence and risk factors. Pediatr 2001; 108: E26
3. Mammel MC, De Regnier RA. Barotrauma, oxygen toxicity, and chronic lung disease. Pediatr 2001; 108: 525
4. Groneck P, Speer CP. Die pathogenese der bronchopulmonalen dysplasie. Z Geburtsh Neonatol 1995; 199: 181-189
5. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275: L110-117
6. Hannaford K, Todd DA, Jeffery H, John E, Byth K, Gilbert GL. Role of Ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 1999; 81: 162-167
7. Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 1998; 17: 321-328
8. Wang EE, Ohlsson A, Kellner JD. Association of Ureaplasma urealyticure colonization with chronic lung disease of prematurity: Results of a metaanalysis. J of Pediatr 1995; 127: 640-644
9. Van Waarde WM, Brus F, Okken A, Kimpen JLL. Ureaplasma urealyticum colonization, prematurity and bronchopulmonary dysplasia. Eur Respir J 1997: 10: 886-890
10. Da Silva O, Gregson D, Hammerberg O. Role of Ureaplasma urealyticum and Chlamydia trachomatis in development of bronchopulmonary dysplasia in very low birth weight infants. Pediatr Infect Dis J 1997; 16: 364-369
11. Van Overmeire B, Follens J, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal ED 1997; 76: 179-184
12. Halliday HL, Ehrenkranz RA. Moderately early (7-14 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2001; 1: CD 001144
13. Brunner H, Bredt W, Krauss H, Pelz K, Schiefer HG, Weidner W. Isolierung und identifizierung von Mykoplasmen und Chlamydien. Z Bakter 1989; A 270: 470-486
14. Brunner H, Weidner W, Schiefer HG. Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in Prostatitis. J Infect Dis 1983; 147: 807-813
15. Brunner H, Weidner W, Schiefer HG. Quantitative studies on the role of Ureaplasma urealyticum in non-gonococcal urethritis and chronic prostatitis. YJ of Bio Med 1983; 56: 545-550
16. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001; 160: 457-463
17. Ogawa Y. Chronic lung disease of the very low birth weight infant - Is it preventable? Turk J Pediatr 1998; 40: 35-44
18. Ramsay PL, O'Brian-Smith E, Hegemier S, Welty SE. Early clinical markers for the development of bronchopulmonary dysplasia: Soluble E-Selectin and ICAM-1. Pediatr 1998; 102: 927-932
19. Abele-Horn M, Genzel-Borovicény O, Uhlig T, Zimmermann A, Peters J, Scholz M. Ureaplasma urealyticum colonization and bronchopulmonary dysplasia: A comparative prospektive multicentre study. Eur J Pediatr 1998; 157: 1004-1011
20. Jónsson B, Rylander M, Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr 1998; 87: 1079-1084
21. Jónsson B, Karrell AC, Ringertz S, Rylander M, Faxelius G. Neonatal Ureaplasma ureatyticum colonization and chronic lung disease. Acta Paediatr 1994; 83: 927-930
22. Sanchez PJ, Regan JA. Vertical transmission of Ureaplasma urealyticum in full term infants. Pediatr Infect Dis J 1990; 9: 398-401
23. Garland SM, Bowman ED. Role of Ureaplasma urealyticum and Chlamydia trachomatis in lung disease in low birth weight infants. Pathol 1996; 28: 266-269
24. Korhonen P, Tammela O, Koivisto AM, Laippala P, Ikonen S. Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants. Early Hum Dev 1999; 54: 245-258
25. Gortner L, Schroeder P, Schaible Th, Möller J, Teichert HM. Steigende inzidenz der bronchopulmonalen dysplasie? Monatsschr Kinderheilkd 1996; 144: 895-900
26. Galetto Lacour A, Zamora S, Bertrand R, Brighi Perret L, Auckentha Berner M, Suter S. Colonization by Ureaplasma urealyticurn and chronic lung in premature newborn infants under 32 weeks of gestation. Arch Pediatr 2001; 8: 39-46
27. Bhandari V, Hussain N, Rosenkrantz T, Kresch M. Respiratory tract colonization with Mykoplasma species increases the severity of bronchopulmonary dysplasia. J Perinat Med 1998; 26: 37-42
28. Pacifico L, Panero A, Roggini M, Rossini N, Bucci G, Chiesa C. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 1997; 16: 579-586
29. Lyon AJ, McColm J, Middlemist L, Fergusson S, McIntosh N, Ross PW. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Fetal Neonatal Ed 1998; 78: 10-14